Genetic Technologies Executes Amendment to Agreement with Quest | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian genetics testing firm Genetic Technologies today said today it has executed an amendment to the Non-Coding License Agreement issued to Quest Diagnostics in 2003.

The amendment extends the terms of the Quest's original non-coding license to "regularize Quest's historical" worldwide activities related to its genetic diagnostic and analysis products. Terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.